Literature DB >> 23462119

Cardiac remodeling during and after renin-angiotensin system stimulation in Cyp1a1-Ren2 transgenic rats.

Bart F J Heijnen1, Leonie P J Pelkmans, A H Jan Danser, Ingrid M Garrelds, John J Mullins, Jo G R De Mey, Harry A J Struijker-Boudier, Ben J A Janssen.   

Abstract

This study investigated renin-angiotensin system (RAS)-induced cardiac remodeling and its reversibility in the presence and absence of high blood pressure (BP) in Cyp1a1-Ren2 transgenic inducible hypertensive rats (IHR). In IHR (pro)renin levels and BP can be dose-dependently titrated by oral administration of indole-3-carbinol (I3C). Young (four-weeks old) and adult (30-weeks old) IHR were fed I3C for four weeks (leading to systolic BP >200 mmHg). RAS-stimulation was stopped and animals were followed-up for a consecutive period. Cardiac function and geometry was determined echocardiographically and the hearts were excised for molecular and immunohistochemical analyses. Echocardiographic studies revealed that four weeks of RAS-stimulation incited a cardiac remodeling process characterized by increased left ventricular (LV) wall thickness, decreased LV volumes, and shortening of the left ventricle. Hypertrophic genes were highly upregulated, whereas in substantial activation a fibrotic response was absent. Four weeks after withdrawal of I3C, (pro)renin levels were normalized in all IHR. While in adult IHR BP returned to normal, hypertension was sustained in young IHR. Despite the latter, myocardial hypertrophy was fully regressed in both young and adult IHR. We conclude that (pro)renin-induced severe hypertension in IHR causes an age-independent fully reversible myocardial concentric hypertrophic remodeling, despite a continued elevated BP in young IHR.

Entities:  

Keywords:  Cyp1a1-Ren2 transgenic rat; Renin–angiotensin system; cardiac remodeling; fibrosis; heart failure; hypertrophy

Mesh:

Substances:

Year:  2013        PMID: 23462119     DOI: 10.1177/1470320313480537

Source DB:  PubMed          Journal:  J Renin Angiotensin Aldosterone Syst        ISSN: 1470-3203            Impact factor:   1.636


  6 in total

1.  Breeding Characteristics and Dose-dependent Blood Pressure Responses of Transgenic Cyp1a1-Ren2 Rats.

Authors:  Catherine J Leader; Barbara J Clark; Amber R Hannah; Ivan A Sammut; Gerard T Wilkins; Robert J Walker
Journal:  Comp Med       Date:  2018-09-05       Impact factor: 0.982

2.  Increased sympathetic drive during the onset of hypertension in conscious Cyp1a1-Ren2 rats.

Authors:  Su Young Han; Emily Gray; Gillian Hughes; Colin H Brown; Daryl O Schwenke
Journal:  Pflugers Arch       Date:  2013-08-25       Impact factor: 3.657

3.  Gradual hypertension induction in middle-aged Cyp1a1-Ren2 transgenic rats produces significant impairments in spatial learning.

Authors:  Mari N Willeman; Monica K Chawla; Marc A Zempare; Lauren A Biwer; Lan T Hoang; Ajay R Uprety; Megan C Fitzhugh; Matthew De Both; Paul D Coleman; Theodore P Trouard; Gene E Alexander; Kenneth D Mitchell; Carol A Barnes; Taben M Hale; Matthew Huentelman
Journal:  Physiol Rep       Date:  2019-03

4.  Left Ventricular Dysfunction and CXCR3 Ligands in Hypertension: From Animal Experiments to a Population-Based Pilot Study.

Authors:  Raffaele Altara; Yu-Mei Gu; Harry A J Struijker-Boudier; Lutgarde Thijs; Jan A Staessen; W Matthijs Blankesteijn
Journal:  PLoS One       Date:  2015-10-27       Impact factor: 3.240

5.  Mild oxidative damage in the diabetic rat heart is attenuated by glyoxalase-1 overexpression.

Authors:  Olaf Brouwers; Joyce M J de Vos-Houben; Petra M G Niessen; Toshio Miyata; Frans van Nieuwenhoven; Ben J A Janssen; Geja Hageman; Coen D A Stehouwer; Casper G Schalkwijk
Journal:  Int J Mol Sci       Date:  2013-07-29       Impact factor: 5.923

6.  Exogenous and endogenous angiotensin-II decrease renal cortical oxygen tension in conscious rats by limiting renal blood flow.

Authors:  Tonja W Emans; Ben J Janssen; Maximilian I Pinkham; Connie P C Ow; Roger G Evans; Jaap A Joles; Simon C Malpas; C T Paul Krediet; Maarten P Koeners
Journal:  J Physiol       Date:  2016-08-18       Impact factor: 5.182

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.